Zentalis Pharmaceuticals, Inc.
$2.13
-0.11 (-4.91%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -30.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -50.3%
Own ZNTL?
See how ZNTL contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.